Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» leukemia
leukemia
"Serial killer" T cells obliterate most common type of leukemia | MassDevice.com On Call
Sat, 08/13/11 - 12:20 am
leukemia
patient
Health care
Talon Therapeutics Submits New Drug Application for Marqibo
Yahoo
Mon, 07/18/11 - 10:00 am
Talon Therapeuticsl
Marqibo
leukemia
BioMarin Starts Study on BMN673
Yahoo/Zacks
Sat, 07/16/11 - 11:36 am
Biomarin
BMN673
leukemia
lymphoma
myelodysplastic syndrome
Great Data! Now Lets See More Than 12 Patients
Motley Fool
Sat, 06/11/11 - 10:25 am
Micromet
leukemia
blinatumomab
Micromet Gains After Leukemia Medicine Helps Patients in Study
Bloomberg
Fri, 06/10/11 - 09:21 am
Micromet
leukemia
blinatumomab
Five-Year Follow-Up Data for SPRYCEL® (dasatinib) 100 mg Once Daily Demonstrated 78 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukemia Resistant or Intolerant to Gleevec®*
BusinessWire
Sat, 06/4/11 - 10:53 am
Sprycel
Bristol-Myers Squibb
leukemia
3 Late-Stage Leukemia Company Previews for ASCO 2011
Seeking Alpha
Mon, 05/9/11 - 10:31 am
ASCO
leukemia
Celgene
Cyclacel
Sunesis
Supergen
Eisai
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
Yahoo/PR NewsWire
Mon, 01/31/11 - 07:46 am
Inovio
acute myeloid leukemia
chronic myeloid leukemia
leukemia
Elgen 1000
cancer vaccines
Novartis leukemia drug approved in Japan
Marketwatch
Tue, 12/21/10 - 09:59 am
Novartis
leukemia
Tasigna
Japan
Novartis: Tasigna surpasses Glivec in study
Fierce Pharma
Mon, 12/6/10 - 11:23 am
Tasigna
Glivec
Novartis
leukemia
BioCryst Reports New Data from Its Phase 2 Forodesine Study in Patients with Chronic Lymphocytic Leukemia at the 52nd Annual American Society of Hematology Meeting
Yahoo/BusinessWire
Sat, 12/4/10 - 12:04 pm
Biocryst
Forodesine
leukemia
chronic lymphocytic leukemia
FDA expands approval of Bristol-Myers leukemia drug to patients newly diagnosed with disease
Yahoo/AP
Thu, 10/28/10 - 10:07 pm
leukemia
Sprycel
Bristol-Myers Squibb
Genzyme's Clolar fails late-stage leukemia study
Yahoo/AP
Wed, 10/20/10 - 12:16 pm
Clolar
Genzyme
leukemia
Seattle Genetics' Cancer Drug Fails
TheStreet.com
Mon, 09/13/10 - 12:22 pm
Seattle Genetics
leukemia
lintuzumab
Trubion shares skyrocket after Emergent deal announced
bizjournals
Sat, 08/14/10 - 12:16 pm
Trubion
Emergent BioSolutions
arthritis
lupus
non-Hodgkin's lymphoma
leukemia
FDA: Pfizer will pull ineffective leukemia drug
Yahoo/AP
Tue, 06/22/10 - 08:53 am
FDA
Pfizer
leukemia
Mylotarg
Bristol-Myers Rises After Drugs Combat Skin, Blood Malignancies
Bloomberg
Mon, 06/7/10 - 09:54 am
Bristol-Myers Squibb
Sprycel
leukemia
Gleevec
Novartis
CytRx Initiates Phase 2 Clinical Trial with Bafetinib in B-cell Chronic Lymphocytic Leukemia
Yahoo/Business Wire
Sat, 05/29/10 - 09:26 am
CytRx
leukemia
Bafetinib
ChemGenex Shares Plunge After Panel Ruling on Drug
Bloomberg
Tue, 03/23/10 - 08:58 am
ChemGenex
FDA
Omapro
leukemia
Ariad cancer treatment gets 'orphan drug' status
Yahoo/AP
Mon, 03/1/10 - 10:49 am
orphan drugs
Ariad Pharmaceuticals
leukemia
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »